Epic Sciences Metastatic Breast Cancer Circulating Tumor Cell Panel

Epic Sciences has released a new single-cell profiling panel for metastatic breast cancer, which alllows analysis of a wide variety of targets, including tumor cell burden, clinically relevant hormone receptor status, and genomic drivers. The panel also enables evaluation of individual CTCs for phenotypic heterogenaity and for novel morphologic signatures that can indicate things like homologous recombination deficiency.